Stada has acquired a portfolio of six OTC brands from GSK that will expand its Consumer Health business in Europe as well as selected APAC and Latin American markets.
Stada is aiming to expand its Consumer Health unit in Europe as well as selected Asia-Pacific and Latin American markets by acquiring a basket of six over-the-counter brands from GlaxoSmithKline.
The six brands – five of which are topical skincare brands, and the other of which is a pediatric cough...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
